MarketLens

Log in

What Does Director Kirwin's Recent Insider Buy Signal for ProMIS Neurosciences

2 months ago
SHARE THIS ON:

What Does Director Kirwin's Recent Insider Buy Signal for ProMIS Neurosciences

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News1 week ago

Wall Street Analysts See a 230.23% Upside in Promis Neurosciences (PMN): Can the Stock Really Move This High?

Promis Neurosciences (PMN) has a mean analyst price target implying 230.2% upside, though this metric alone is unreliable. Strong consensus among analysts in raising earnings estimates suggests potent...
Stock News2 weeks ago

What a $350,000 Insider Sale Might Mean for Mineralys Ahead of December FDA Decision

Mineralys shares fell after a $350,000 insider sale, ahead of a December FDA decision on its hypertension therapy.
Stock News3 weeks ago

Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman

Tiziana Life Sciences' Executive Chairman purchased shares, signaling insider confidence. The transaction involves the biotech's lead candidate, intranasal foralumab.
Stock News1 months ago

Hims & Hers Stock Spikes -- Insider Sends Strong Signal With $1 Million Buy

Hims & Hers Health (HIMS) shares rose ~5% on Wednesday after director David Wells disclosed a $1M purchase of company stock. The insider acquisition signals management confidence in the firm's current...

Breaking News

View All →

Top Headlines

View More →
Stock News27 minutes ago

Meta Launches New Image Generation Tool for Consumers and Businesses

Stock News1 hour ago

Here's what Microsoft is offering laid-off employees in severance

Stock News1 hour ago

Why Palantir Stock Ticked Higher on Tuesday

Stock News1 hour ago

Meta Platforms (META) Rises As Market Takes a Dip: Key Facts

Stock News1 hour ago

Tesla (TSLA) Dips More Than Broader Market: What You Should Know